BRUSSELS, Oct 24 (Reuters) - EU antitrust regulators
will decide by Nov. 28 whether to clear Danish food ingredients
and enzymes makers Novozymes NZYMb.CO and Chr. Hansen's
CHRH.CO tie-up, according to a European Commission filing.
The companies, which announced the deal in December last
year, sought EU approval for the merger last Friday.
The EU competition enforcer can decide to clear the deal
with or without remedies after its preliminary review or it can
open a four-month long investigation if it has serious concerns.
Chr. Hansen focuses on enzymes and microbials for the food
sector, while Novozymes' largest business areas include enzymes
for household products, food and beverages and biofuels.
(Reporting by Foo Yun Chee; editing by Barbara Lewis)
((foo.yunchee@thomsonreuters.com; +32 2 585 2866; Reuters
Messaging: foo.yunchee.thomsonreuters.com@reuters.net))